833 related articles for article (PubMed ID: 16493590)
1. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
2. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.
Lee WR; Shen SC; Pai MH; Yang HH; Yuan CY; Fang JY
J Control Release; 2010 Jul; 145(2):124-33. PubMed ID: 20359510
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.
Fang JY; Lee WR; Shen SC; Fang YP; Hu CH
Br J Dermatol; 2004 Jul; 151(1):132-40. PubMed ID: 15270882
[TBL] [Abstract][Full Text] [Related]
4. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
5. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
6. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors.
Jain AK; Lee CH; Gill HS
J Control Release; 2016 Oct; 239():72-81. PubMed ID: 27543445
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
9. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas.
af Klinteberg C; Enejder AM; Wang I; Andersson-Engels S; Svanberg S; Svanberg K
J Photochem Photobiol B; 1999 Apr; 49(2-3):120-8. PubMed ID: 10392462
[TBL] [Abstract][Full Text] [Related]
10. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid.
Tope WD; Ross EV; Kollias N; Martin A; Gillies R; Anderson RR
Photochem Photobiol; 1998 Feb; 67(2):249-55. PubMed ID: 9487802
[TBL] [Abstract][Full Text] [Related]
11. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy.
De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV
J Control Release; 2000 Apr; 65(3):359-66. PubMed ID: 10699294
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
van der Veen N; de Bruijn HS; Berg RJ; Star WM
Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
Fang YP; Tsai YH; Wu PC; Huang YB
Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
[TBL] [Abstract][Full Text] [Related]
14. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
15. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
16. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
17. Skin laser treatments enhancing transdermal delivery of ALA.
Gómez C; Costela Á; García-Moreno I; Llanes F; Teijón JM; Blanco MD
J Pharm Sci; 2011 Jan; 100(1):223-31. PubMed ID: 20589948
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
19. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
20. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
